Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126436501 | 12643650 | 1 | I | 20160505 | 20160811 | 20160811 | EXP | PHFR2016GB003844 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160811 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126436501 | 12643650 | 1 | PS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 180 MG, UNK | U | 50791 | 180 | MG | TABLET | ||||||
| 126436501 | 12643650 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, UNK | U | 0 | 1 | MG | TABLET | ||||||
| 126436501 | 12643650 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 5 MG, UNK | U | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126436501 | 12643650 | 1 | Immunosuppression |
| 126436501 | 12643650 | 2 | Immunosuppression |
| 126436501 | 12643650 | 3 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126436501 | 12643650 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126436501 | 12643650 | Malaise | |
| 126436501 | 12643650 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |